<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drug\PMC7291595\results\search\testTrace\results.xml">
  <result pre="No targeted drugs have yet been available for intervention and" exact="treatment" post="of this virus. The sharing of academic information is"/>
  <result pre="and clinical characteristics of the virus as well as laboratory" exact="testing" post="and treatments to understand the nature of the virus."/>
  <result pre="outbreak countries and regions. Keywords:â€‚ clinical characteristics epidemiology genomic laboratory" exact="testing" post="SARS-CoV-2 therapeutics page-count: The 2019-novel coronavirus, which was first"/>
  <result pre="Hopkins resource center). Currently, specific vaccines and medicine for SARS-CoV-2" exact="infection" post="are being developed [16]. This paper summarizes the epidemiological,"/>
  <result pre="the virus. Clinical characteristics of patients infected with SARS-CoV-2 SARS-CoV-2" exact="infection" post="has caused clusters of severe respiratory illness similar to"/>
  <result pre="The symptoms are observed approximately 5.2Â days after the SARS-CoV-2" exact="infection" post="[5]. In a study published in The Lancet, 41"/>
  <result pre="of 41 patients who were identified as positive for SARS-CoV-2" exact="infection" post="presented with pneumonia and abnormal chest computed tomography (CT)"/>
  <result pre="care unit patients. One study showed that during the early" exact="infection" post="period, most patients had normal white blood cell counts;"/>
  <result pre="however, 56.8% of patients had leukopenia in cases of serious" exact="infection" post="[46]. Patients with dyspnea were more frequently admitted to"/>
  <result pre="of the large amounts of cytokines produced during SARS-CoV infection," exact="infection" post="with SARS-CoV-2 similarly induces the production of proinflammatory cytokines"/>
  <result pre="T-helper type 2 [Th2] cells was also increased during SARS-CoV-2" exact="infection" post="[6]) (TableÂ 1). The mortality rate of SARS-CoV-2-infected patients"/>
  <result pre="rate as compared with two other related coronaviruses. Diagnostic laboratory" exact="testing" post="Hematology testing The number of total leukocytes, lymphocytes and"/>
  <result pre="compared with two other related coronaviruses. Diagnostic laboratory testing Hematology" exact="testing" post="The number of total leukocytes, lymphocytes and monocytes has"/>
  <result pre="more prominent abnormalities than those with non-severe cases. Nucleic acid" exact="testing" post="Virus from throat swabs, blood, urine, stool or respiratory"/>
  <result pre="than that of the N gene, and the limit of" exact="detection" post="(LOD) of RdRp/Hel and N gene was lower than"/>
  <result pre="was significantly more sensitive than the RdRp-P2 assay for the" exact="detection" post="of SARS-CoV-2 RNA, and detection targeted ORF1a/b, ORF1b-nsp14, RdRp,"/>
  <result pre="the RdRp-P2 assay for the detection of SARS-CoV-2 RNA, and" exact="detection" post="targeted ORF1a/b, ORF1b-nsp14, RdRp, S, E or N genes"/>
  <result pre="helped to reduce the false-negative rate and improve the laboratory" exact="diagnosis" post="of COVID-19 [18]. SARS-CoV-2 viral load is detectable from"/>
  <result pre="by novel assay methods [58]. The sample quality, collection time," exact="detection" post="kits and technical abilities of clinical doctors may affect"/>
  <result pre="clinical doctors may affect the accuracy of detection. Therefore, precise" exact="diagnosis" post="of COVID-19 should be combined with CT scans and"/>
  <result pre="also been used to identify patients with suspected infection. Serology" exact="testing" post="In addition to hematological detection and nucleic acid testing,"/>
  <result pre="patients with suspected infection. Serology testing In addition to hematological" exact="detection" post="and nucleic acid testing, serological diagnosis is important for"/>
  <result pre="In addition to hematological detection and nucleic acid testing, serological" exact="diagnosis" post="is important for patients who present late with a"/>
  <result pre="present late with a very low viral load, below the" exact="detection" post="limit of RT-PCR assays [59]. IgM and IgG titers"/>
  <result pre="be virally negative [61]. Therefore, virus-specific IgM and IgG serological" exact="testing" post="may be used to confirm current or previous infection"/>
  <result pre="serological testing may be used to confirm current or previous" exact="infection" post="with SARS-CoV-2. Animal models for COVID-19 An ideal animal"/>
  <result pre="mustached tamarins) have all been evaluated as models of SARS-CoV" exact="infection" post="[62]. All non-human primates had pneumonia, cough and respiratory"/>
  <result pre="non-human primates had pneumonia, cough and respiratory distress after virus" exact="infection" post="[15]. Mice (BALB/c, C57BL6 and 129S strains) supported SARS-CoV"/>
  <result pre="they harbored high viral titers and pulmonary histopathology upon virus" exact="infection" post="[63]. Ferrets are another appropriate animal model to study"/>
  <result pre="histologic changes were similar to those of patients with virus" exact="infection" post="[63]. ACE2, the receptor of SARS-CoV, was also identified"/>
  <result pre="addition, the domestic cat has shown multifocal pulmonary consolidation with" exact="infection" post="of SARS-CoV, and SARS-CoV-2 can replicate efficiently in cats"/>
  <result pre="COVID-19 No specific therapeutic medicine has been approved for the" exact="treatment" post="of SARS-CoV-2 infection. All patients are given empirical antibiotic"/>
  <result pre="aureus and is combined with nemonoxacin in cases of severe" exact="infection" post="[65]. A combination of lopinavir and ritonavir has been"/>
  <result pre="predicted to be efficacious against COVID-19 by target-based virtual ligand" exact="screening" post="[68]. RDV is a novel nucleotide analog prodrug that"/>
  <result pre="has demonstrated effective pan-CoV therapy. The first case of SARS-CoV-2" exact="infection" post="in the USA was successfully treated with RDA. Moreover,"/>
  <result pre="[45]. Oseltamivir, a neuraminidase inhibitor, is recommended as an antiviral" exact="treatment" post="for influenza and has been widely used to inhibit"/>
  <result pre="also needs further study. Arbidol (ARB) was licensed for the" exact="treatment" post="of influenza and other respiratory viral infections in Russia"/>
  <result pre="have been commonly used in patients with SARS-CoV or MERS-CoV" exact="infection" post="[74,75]. Glucocorticoids prolonged the survival time of SARS cases"/>
  <result pre="China. However, the mortality rate did not decrease with corticosteroid" exact="treatment" post="in patients infected with SARS-CoV-2, and viral clearance was"/>
  <result pre="[77]. Chloroquine was suggested to treat COVID-19 in the SARS-CoV-2" exact="treatment" post="guidelines by the Chinese medical advisory. Chloroquine has been"/>
  <result pre="IFN-Î± combined with LPV/r was shown to be beneficial for" exact="treatment" post="of COVID-19 [78]. Tocilizumab is a humanized anti-IL-6-receptor (IL-6R)"/>
  <result pre="antibody that inhibits IL-6 signaling and is used as a" exact="treatment" post="in rheumatoid arthritis [79]. IL-6 is one of the"/>
  <result pre="wild animals was also restricted, and travel was reduced with" exact="screening" post="at airports, railway stations and subway stations [84]. Moreover,"/>
  <result pre="isolated any suspected cases as rapidly as possible to contain" exact="infection" post="and prevent local outbreaks. The ability to rapidly test"/>
  <result pre="ability to rapidly test patients suspected of having a SARS-CoV-2" exact="infection" post="is the cornerstone of case isolation. The experience gained"/>
  <result pre="fever, cough, shortness of breath, leukopenia and pneumonia. Diagnostic laboratory" exact="testing" post="of COVID-19 includes hematology testing, nucleic acid testing, viral"/>
  <result pre="infection. Traditional Chinese medicines are also used for therapy during" exact="infection" post="with SARS-CoV-2. This review is presented in the hope"/>
  <result pre="497â€&quot;506 (2020). 31986264 â€¢ Provides the first evidence for the" exact="diagnosis" post="and treatment of COVID-19 patients. The common symptoms among"/>
  <result pre="31986264 â€¢ Provides the first evidence for the diagnosis and" exact="treatment" post="of COVID-19 patients. The common symptoms among 41 patients"/>
  <result pre="Infection48(2), 155â€&quot;163 (2020).32072569 18.ChanJF , YipCC , ToKKet al.Improved molecular" exact="diagnosis" post="of COVID-19 by the novel, highly sensitive and specific"/>
  <result pre="showed that the COVID-19-RdRp/Hel assay had the lowest limit of" exact="detection" post="in vitro and did not cross-react with other human-pathogenic"/>
  <result pre=", ZhengX , LiuY , LiX , ShanHEvidence for gastrointestinal" exact="infection" post="of SARS-CoV-2. Gastroenterology158(6), 1831â€&quot;1833 (2020).32142773 28.ChenY , ChenL ,"/>
  <result pre="The study is helpful to the radiologist for the early" exact="detection" post="and diagnosis of this disease. 48.SongF , ShiN ,"/>
  <result pre="is helpful to the radiologist for the early detection and" exact="diagnosis" post="of this disease. 48.SongF , ShiN , ShanFet al.Emerging"/>
  <result pre=", WangTet al.Diagnosis, treatment, and prevention of 2019 novel coronavirus" exact="infection" post="in children: experts' consensus statement. World J. Pediatr. (2020)"/>
  <result pre="in posterior oropharyngeal saliva samples and serum antibody responses during" exact="infection" post="by SARS-CoV-2: an observational cohort study. Lancet Infect. Dis.20(5),"/>
  <result pre=", HuangGet al.Comparison of different samples for 2019 novel coronavirus" exact="detection" post="by nucleic acid amplification tests. Int. J. Infect. Dis.93,"/>
  <result pre="264â€&quot;267 (2020).32114193 59.TangYW , SchmitzJE , PersingDH , StrattonCWThe laboratory" exact="diagnosis" post="of COVID-19 infection: current issues and challenges. J. Clin."/>
  <result pre="Al-AliAY , Al-TawfiqJAA systematic review of therapeutic agents for the" exact="treatment" post="of the Middle East respiratory syndrome coronavirus (MERS-CoV). Travel"/>
  <result pre="9â€&quot;18 (2019).31252170 67.StockmanLJ , BellamyR , GarnerPSARS: systematic review of" exact="treatment" post="effects. PLoS Med.3(9), e343 (2006).16968120 68.YangY , PengF ,"/>
  <result pre="single-centered, retrospective, observational study. Lancet Resp. Med.8(5), 475â€&quot;481 (2020). 70.LuHDrug" exact="treatment" post="options for the 2019-new coronavirus (2019-nCoV). Biosci. Trends14(1), 69â€&quot;71"/>
  <result pre="in patients hospitalized for suspected Middle East respiratory syndrome coronavirus" exact="infection" post="in the Paris area from 2013 to 2016. BMC"/>
  <result pre="74.RussellCD , MillarJE , BaillieJKClinical evidence does not support corticosteroid" exact="treatment" post="for 2019-nCoV lung injury. Lancet395(10223), 473â€&quot;475 (2020).32043983 75.PanesarNSWhat caused"/>
  <result pre=", LiuY , QiuL , LiuX , LiuD , LiJTocilizumab" exact="treatment" post="in COVID-19: a single center experience. J. Med. Virol."/>
  <result pre=", CaiL , ChengZSet al.A rapid advice guideline for the" exact="diagnosis" post="and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia"/>
  <result pre=", ChengZSet al.A rapid advice guideline for the diagnosis and" exact="treatment" post="of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version)."/>
 </snippets>
</snippetsTree>
